About us ...
Novo Nordisk has the broadest diabetes product portfolio in the industry. We also have a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
IC/CGFF/SGUA
Last updated: 12 February 2008
|
